Catalyst Wire Dossier Catalyst Wire Dossier

trevogrumab

trevogrumab · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for trevogrumab, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation [Phase 2]

See pricing